Adjuvanted Enterovirus 71 Vaccine Is Highly Effective in Infants and Children
Researchers assessed the efficacy of an adjuvanted enterovirus 71 (EV71) vaccine for the prevention of EV71-associated infections among infants and children.
Researchers assessed the efficacy of an adjuvanted enterovirus 71 (EV71) vaccine for the prevention of EV71-associated infections among infants and children.
Researchers conducted a retrospective review that evaluated the field effectiveness of tick-borne encephalitis vaccination across all patient age groups.
Researchers conducted a study to determine whether homologous COVID-19 vaccination increases in vitro neutralizing activity against seasonal human coronaviruses.
Researchers sought to assess outcomes among patients in South Africa who were hospitalized with COVID-19 infection during the Omicron wave compared with previous waves.
During a season predominated by 2 vaccine-mismatched viruses, vaccination was estimated to reduce the risk of life-threatening influenza illness by 75%.
Researchers conducted a study to determine the safety and efficacy of the Ad5-nCoV vaccine for protection against SARS-CoV-2 infection in adult patients.
Researchers conducted a study to determine the effect of a national human papillomavirus (HPV) immunization program on the incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia among young women in England.
To answer the many questions regarding the roll out, risk and benefits, and timing of COVID-19 vaccine administration in children aged 5 to 11 years, The Clinical Advisor interviewed Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP, a pediatric nurse practitioner and owner of Pediatric Nurse Practitioner House Calls.
Having the tough conversations. NASEM offers recommendations for communicating with parents of young children about COVID-19 vaccines.
Despite the availability of a highly effective shingles vaccine and almost universal risk among those born before 1980, Americans are not getting vaccinated.